Immune system overreactions may be the true culprit of cardiac illness—and lifesaving drugs can calm them down ...

GLP-1 receptor agonists such as semaglutide are changing the way type 2 diabetes and obesity are treated. But these drugs have also shown a surprising ability to improve cardiovascular health — and ...

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, posing a major challenge to health systems. There are a variety of ...

People who stop taking popular weight-loss and diabetes medications may lose out on any heart health benefits the medications provided. GLP-1 receptor agonists — such as semaglutide (Ozempic and ...

Trial results showing that a potent anti-obesity drug offers strong protection against serious heart problems have electrified researchers. They say that the findings could change how this and other ...

Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ...

Cardiovascular diseases are the number one cause of death globally. They include conditions such as coronary heart disease (CHD), heart attack, high blood pressure, arrhythmias, congenital heart ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also ...

Repurposing existing, approved medications is always a great plan to get therapeutics to patients in need much more rapidly. And for disorders of the kidneys, speed is of the essence. Now, a new study ...

MDMA can increase your heart rate and blood pressure, which may be harmful if you already have a cardiovascular condition. MDMA (3,4-methylenedioxy-methamphetamine) is a synthetic drug that elevates ...